Products
World-class data science drives analytics and applications all accessible from the IntegriChain ICyte Platform combined with outstanding leading Managed Service offerings
Browse All IntegriChain Products
Contracts & Pricing
Government Pricing
Rebate Management
Chargeback Management
GTN
340B Analytics
Patient Journey
Patient Data Refinery
Specialty Pharmacy Analytics
Channel
Distribution Data Refinery
Inventory Analytics
Retail Analytics
Distribution Contract Management
Gross-to-Net
GTN Accruals
GTN Forecasts
Government Pricing
We are an industry leader in Government Pricing Managed Services, providing all relevant calculations required for the Medicaid, Medicare, PHS, and FSS programs. Our GP services are expertly designed with robust data cleansing and standardization, automated data load process, and comprehensive and auditable control reports covering all price calculation detail.
Rebate Management
Our Rebate Management Managed Services allow customers to scale their payer analytics and contracting functions to meet today’s complex commercial and government access challenges. Our Rebate Management offering is the industry’s leading provider of claims adjudication, handling all of your needs for your claims payments and rebate processing.
Chargeback Management
IntegriChain’s Chargeback Management Managed Services offers a full suite of chargeback reconciliation and analytics capabilities across GPO/IDN provider and federal contracts such as 340B and FSS. Our offerings marry expert contract management along with unparalleled chargeback processing, uniquely processing the most comprehensive set of validity checks and delivering operational reporting and wholesaler scorecards to better manage your programs.
Webinar
How to Self Police Revenue Leakage due to 340B Program Non-Compliance
There is broad agreement across the pharmaceutical industry and Congress that that 340B program needs more oversight and statutory change. But with so much congressional paralysis and midterm elections on the horizon, it’s highly unlikely that changes will occur anytime soon. The status quo leaves manufacturers with few remedies for pursuing suspected diversion or duplicate rebate claims generated by providers or pharmacies. In this webinar, we’ll look at examples of non-compliance, specifically diversion and duplicate discounting, that manufacturers and Payers can flag and act on. Using IntegriChain’s analytics platform to crosswalk pharmacy sell-in data, rebates, and chargebacks, we’ll demonstrate how manufacturers can identify non-compliant 340 transactions.
Watch Webinar
Webinar
Launch Readiness for Commercial Contracting and Government Programs: Coverage and Policy Trends
Join us for the first in a series of webinars focused on Access Launch Readiness. We’ll start this series with our new daVIZta colleagues for a great entry point for emerging Life Sciences manufacturers who are planning their launch within the next two years. Jeff Baab and Jen Sharpe will share their thought leadership and experience with payer coverage and policy trends that will affect your go to market Payer strategy and downstream Gross-to-Net impacts.
GTN
Our industry-leading GTN Managed Services and SaaS offerings improve your forecast accuracy, GTN modeling, and financial close efficiency. GTN Accruals is configured for all standard line items with robust out-of-the-box accrual methodologies; GTN Forecasts delivers industry-standard forecast methodologies configured for each liability line item, along with reports and dashboards, allowing you to analyze your GTN liabilities with drill-down and roll-up capabilities.More on GTN
340B Analytics
Your team needs data and analytics solutions to investigate instances of non-compliance, specifically diversion and duplicate discounting. Using our ICyte Platform to crosswalk pharmacy sell-in data, rebates, and chargebacks, your team can identify non-compliant 340B transactions. Our 340B Analytics offers enriched 340B-focused visualizations including commercial and 340B transactions across every covered entity and covered entity site of care, including contract pharmacies.More on 340B Analytics
Patient Data Refinery
The IntegriChain Patient Data Refinery draws on our industry-leading data science and master data management to deliver high-quality specialty data. Poor patient status data quality is preventing your brand from gaining diagnostic, actionable patient journey insights. By utilizing world-class data science to monitor, cleanse, and map aggregated specialty data, IntegriChain’s Patient Data Refinery greatly improves the accuracy and actionability of patient status data. More on Patient Data Refinery
Specialty Pharmacy Analytics
IntegriChain’s Specialty Pharmacy Analytics delivers diagnostic patient journey insights by calibrating the datasets associated with a suite of business KPIs and analytics to reflect the uniqueness of your brand’s patient journey. Our diagnostic analytics for patient initiation, therapy adherence, field reimbursement, hub services, and patient services go a level deeper to uncover the reasons why your patients are struggling to overcome barriers along the patient journey. More on Specialty Pharmacy Analytics
Webinar
Strategies for Data-Driven Field Reimbursement Teams
Facilitating patient access to prescribed specialty therapeutics continues to be a challenge in a difficult managed care environment. Patients need help navigating obstacles that delay therapy initiation, such as prior authorization and rising out-of-pocket costs, and cause interruptions in treatment. Field Reimbursement (FRM) teams need data-driven solutions to triage stalled patient cases, intervene as patients accrue gap days and evaluate the effectiveness of patient engagement. In this webinar, IntegriChain Patient Segment Lead Sean McCarthy will discuss the challenges FRM teams encounter on a regular basis and share a number of data-driven solutions your team can implement to drive results.
Watch Webinar
blog
Specialty Pharmacy Patient Status Data Quality Challenges and Solutions
Without visibility into each individual patient journey, your specialty brand cannot consistently intervene to help patients overcome barriers to therapy initiation and adherence. Today, the poor quality of specialty patient status data is making it impossible to calculate accurate KPI metrics and uncover true patient journey insights. This blog post examines in detail three critical patient status data quality challenges and recommends solutions your specialty brand can implement to overcome these challenges, and ultimately, help patients start therapy faster and stay on therapy longer.
Distribution Data Refinery
IntegriChain Distribution Data Refinery provides an end-to-end view of product distribution starting with life sciences supplier sales on through distributor inventory, distributor sales, chain DC inventory, store inventory, returns, and POS demand. This offering delivers a core suite of functionality that includes data sets, aggregation, QA/QC, master data management, and access through business intelligence capabilities.
Inventory Analytics
Manufacturers have few existing measures of the inventory held in retail stores, distribution centers, and third-party returns processors. IntegriChain Inventory Analytics reports 100% of inventory in the retail channel, even in pharmacy stores and distribution centers that do not report their inventories.
Webinar
Unlock the Power of Scorecard Analytics to Maximize Pay-for-Performance
This webinar covers major enhancements to trade partner scorecard functionality found within IntegriChain Distribution Analytics. These enhancements allow Scorecard users to utilize robust trade partner agreement data to further maximize pay-for-performance by analyzing channel investment against performance through IntegriChain's powerful Data on Demand and reporting tools.
Blog
Leveraging Distributor Contract Management to Optimize Evolving DSAs
As distribution service agreements evolve over time, manufacturers must have the ability to run what-if analyses on actual scorecard data to analyze the overall effect various changes under consideration would have on trade partner payments. In this post, we look at how Distributor Contract Management can be leveraged to optimize changes to DSAs.
Retail Analytics
Retail Analytics super-boosts the insights delivered in our Pharmacy enriched dataset, IntegriChain’s competitive market deciles, and critical patient access data assets by adding key patient journey insights. With Retail Analytics, manufacturers can identify the specific pharmacies where a brand is performing or underperforming combined with the payer/plan, tier, out-of-pocket, and policy restriction context in the pharmacy’s surrounding patient population.
Distribution Contract Management
Distribution Contract Management is a single, auditable application for managing all aspects of trade partner agreements. Configurable trade partner scorecard functionality features payment adjudication, custom pay-for-performance metrics, payment roll forward, and top- and bottom-line functionality adjustments. These functions are automated and facilitate standardized contract negotiations with trade partners. Manufacturers can also monitor trade partner purchase orders in real time and make decisions based on channel inventory and order quantity.More on Distribution Contract Management